Clinical Trials
Biocons Insulin Manufacturing Facility in Malaysia Completes U.S. FDA Inspection
This is to inform you that the U.S. FDA conducted a pre-approval inspection (PAI) of our subsidiary, Biocon Sdn. Bhd’s Insulins manufacturing facility based in...
Clinical Trials
Spring Bank Pharmaceuticals in Clinical Collaboration With Roche
Spring Bank Pharmaceuticals Inc. said it has entered into a new clinical collaboration with Roche to explore the co-administration of SB 11285, Spring Bank's intravenously-administered...
Clinical Trials
Light Chain Bioscience Successfully Completes Factor VIII Mimetic Bispecific Antibody Discovery
Light Chain Bioscience has achieved a milestone and received a payment under its research and collaboration agreement with Takeda Pharmaceutical. The milestone was achieved upon...
Clinical Trials
Chiesi Group Announces Establishment of New Global Rare Diseases Division
Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced the formation of Chiesi Global Rare Diseases, a new business unit that will harness...
Clinical Trials
Iddi intensifies global debate on the future of randomized trials in Clinical Research
International Drug Development Institute (IDDI), a leading therapy-focused Biostatistics and eClinical Services corporation based in Belgium with offices in Boston (MA) and Raleigh (NC) announces...
Clinical Trials
AIVITA Biomedical completes patient enrollment target in phase 2 GBM trial for glioblastoma
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that it has reached its patient enrollment target in the company's phase...
Clinical Trials
Sanofis phase 2 study of BTK inhibitor, SAR442168 meets primary endpoint to treat MS
The Sanofi phase 2b study evaluating its investigational BTK (Brutons tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieved its primary endpoint.
In the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.